SELARL GRANDE PHARMACIE DU CENTRE : revenue, balance sheet and financial ratios

SELARL GRANDE PHARMACIE DU CENTRE is a French company founded 22 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAVIGNY-LE-TEMPLE (77176), this company of category PME shows in 2021 a revenue of 2.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL GRANDE PHARMACIE DU CENTRE (SIREN 452193923)
Indicator 2024 2023 2021 2019 2018 2017 2016 2015
Revenue N/C N/C 2 654 459 € N/C N/C N/C N/C 2 280 138 €
Net income 114 913 € 69 115 € 166 614 € 140 927 € 112 597 € 116 823 € 108 363 € 106 589 €
EBITDA N/C N/C 287 942 € N/C N/C N/C N/C 191 808 €
Net margin N/C N/C 6.3% N/C N/C N/C N/C 4.7%

Revenue and income statement

In 2024, SELARL GRANDE PHARMACIE DU CENTRE generates positive net income of 115 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2024: 107 k€ -> 115 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

114 913 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 401%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 15%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

400.712%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

15.034%

Solvency indicators evolution
SELARL GRANDE PHARMACIE DU CENTRE

Sector positioning

Debt ratio
400.71 2024
2021
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average +49 pts over 3 years

In 2024, the debt ratio of SELARL GRANDE PHARMACIE D... (400.71) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
15.03% 2024
2021
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch -41 pts over 3 years

In 2024, the financial autonomy of SELARL GRANDE PHARMACIE D... (15.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
1.01 years 2021
2021
Q1: 1.06 years
Med: 3.56 years
Q3: 7.31 years
Excellent

In 2021, the repayment capacity of SELARL GRANDE PHARMACIE D... (1.01) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL GRANDE PHARMACIE DU CENTRE

Positioning of SELARL GRANDE PHARMACIE DU CENTRE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL GRANDE PHARMACIE DU CENTRE is estimated at 1 604 270 € (range 1 117 188€ - 2 400 080€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
1117k€ 1604k€ 2400k€
1 604 270 € Range: 1 117 188€ - 2 400 080€
NAF 5 année 2024

Valuation method used

Net Income Multiple
114 913 € × 14.0x = 1 604 270 €
Range: 1 117 189€ - 2 400 080€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL GRANDE PHARMACIE DU CENTRE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL GRANDE PHARMACIE DU CENTRE

What is the revenue of SELARL GRANDE PHARMACIE DU CENTRE ?

The revenue of SELARL GRANDE PHARMACIE DU CENTRE in 2021 is 2.7 M€.

Is SELARL GRANDE PHARMACIE DU CENTRE profitable?

Yes, SELARL GRANDE PHARMACIE DU CENTRE generated a net profit of 115 k€ in 2024.

Where is the headquarters of SELARL GRANDE PHARMACIE DU CENTRE ?

The headquarters of SELARL GRANDE PHARMACIE DU CENTRE is located in SAVIGNY-LE-TEMPLE (77176), in the department Seine-et-Marne.

Where to find the tax return of SELARL GRANDE PHARMACIE DU CENTRE ?

The tax return of SELARL GRANDE PHARMACIE DU CENTRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL GRANDE PHARMACIE DU CENTRE operate?

SELARL GRANDE PHARMACIE DU CENTRE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.